Advertisement
YOU ARE HERE: LAT HomeCollectionsSeattle Genetics
IN THE NEWS

Seattle Genetics

FEATURED ARTICLES
BUSINESS
October 9, 2002 | Denise Gellene
Seattle Genetics said Tuesday that Genentech ended a three-year collaboration on a possible cancer drug, but analysts said the move would have little effect on either company. Seattle Genetics said it would continue development of SGN-14, a genetically engineered antibody, on its own. It considers the molecule a potential treatment for certain cancers of the blood, such as multiple myeloma and non-Hodgkin's lymphoma. Neither company offered a reason for ending the collaboration.
ARTICLES BY DATE
BUSINESS
October 9, 2002 | Denise Gellene
Seattle Genetics said Tuesday that Genentech ended a three-year collaboration on a possible cancer drug, but analysts said the move would have little effect on either company. Seattle Genetics said it would continue development of SGN-14, a genetically engineered antibody, on its own. It considers the molecule a potential treatment for certain cancers of the blood, such as multiple myeloma and non-Hodgkin's lymphoma. Neither company offered a reason for ending the collaboration.
Advertisement
NEWS
August 15, 1996 | From Times Staff and Wire Reports
Surprisingly skinny mice created in a Seattle genetics lab may offer hints at why some people can eat all they want and still stay thin. Researchers have found that with a single genetic alteration, they can turn up a natural metabolic furnace in mice so the animals burn more fat. Experts said people might eventually be able to control their weight by doing the same thing, or by exploiting related processes.
BUSINESS
February 9, 2001 | From Times Staff and Wire Reports
Is the IPO market showing signs of life? The languishing market for initial public offerings received a much-needed boost Thursday when KPMG Consulting's IPO of more than $2 billion surged 30% in first-day trading. Not only the largest IPO so far this year, but the best performing in terms of first-day gains, the stock sale made KPMG Consulting (ticker symbol: KCIN) one of the world's largest technology companies.
BUSINESS
April 27, 2004 | From Times Staff and Wire Reports
Stocks were broadly lower Monday in a lackluster session dominated by continued worries about interest rates. The market was indecisive for much of the day, with the major indexes fluctuating in and out of positive territory. Prices turned lower near the close as short-term traders stepped away, analysts said. The Dow Jones industrial average lost 28.11 points, or 0.3%, to 10,444.73 after rising the three previous sessions. The Standard & Poor's 500 index was off 5.07 points, or 0.4%, to 1,135.
BUSINESS
July 24, 2011 | By Andrew Leckey
Question: I am a disgruntled Bank of America Corp. shareholder. Is there reason to expect improved results? Answer: The question for shareholders is how quickly the company can put mistakes behind it, significantly improve its controls and use its enormous size to greater advantage. It became the biggest U.S. bank after acquisitions of Countrywide Financial and Merrill Lynch, but in coming months it's likely to slip into second place in assets, behind JPMorgan Chase & Co. Sluggishness stems from bad loans from acquisitions and from lax practices in the past.
NEWS
June 4, 2001 | AARON ZITNER, TIMES STAFF WRITER
Stepping over the stubble of last year's cornstalks, Barry Wiggins used a measuring wheel to pace off an exact acre of farmland. He marked the plot with orange flags, then used a hand-held gizmo to take a satellite reading of its precise location on Earth. Only then did Wiggins rip open a bag of seed corn and pour it into the planting equipment that sat behind his tractor. When the corn sprouts here, it will not look like anything special.
Los Angeles Times Articles
|